The modern approach to the treatment of diffuse - generalized forms of hypertrophic cardiomyopathy in the cardiac surgery
Abstract
To evaluate the results of surgical treatment of patients with diffuse-generalized form of hypertrophic cardiomyopathy by performing extended myectomy ventricular septal longitudinal parietal resection of the hypertrophied papillary muscles and universal mitral valve replacement. We have operated 18 patients (10 men and 8 women) with diffuse-generalized form of hypertrophic cardiomyopathy HCM. The average age of the patients was 48 ± 10,9 years. Hospital mortality was 0%. At 1 year after surgery according echocardiogram thickness of interventricular septum decreased from 1,9 ± 0,3 cm to 1,5 ± 0,2 cm, the pressure gradient in the left ventricular outflow tract decreased from 75,9 ± 5,6 mm. Hg up to 3,2 mm Hg ± 20.4, the size of the left atrium decreased from 4,5 ± 0,4 to 4,2 ± 0,3 cm. The functional class decreased from III to I-II NYHA. In the late postoperative period (2 years), 1 patient died. Conclusion: The results indicate that our proposed method of surgical treatment of diffuse - a generalized form of HCM is an effective procedure that gives good functional results.
About the Authors
A. N. Shapieva
Federal state scientific institution «Russian scientific center of surgery named after academician B. V. Petrovsky»
Russian Federation
Russian Federation
S. V. Fedulova
Federal state scientific institution «Russian scientific center of surgery named after academician B. V. Petrovsky»
Russian Federation
Russian Federation
N. L. Cherepenina
Federal state scientific institution «Russian scientific center of surgery named after academician B. V. Petrovsky»
Russian Federation
Russian Federation
V. S. Klimenko
Federal state scientific institution «Russian scientific center of surgery named after academician B. V. Petrovsky»
Russian Federation
Russian Federation
D. G. Podoliak
Federal state scientific institution «Russian scientific center of surgery named after academician B. V. Petrovsky»
Russian Federation
Russian Federation
References
1. Дземешкевич С. Л., Фролова Ю. В., Ким С. Ю. и др. Анатомические и морфологические признаки диффузно-генерализованной формы гипертрофической кардиомиопатии // Российский кардиологический журнал. - 2015. -№ 5 (121). - С. 58-63.
2. Elliott P. M., Anastasakis A., Borger M. et al. ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy // Eur. heart. j. - 2014. - № 35. - Р. 2733-2779.
3. Minakata K., Dearani J. A., Nishimura R. A., Maron B. J., Danielson G. K. Extended septal myectomy for hypertrophic obstructive cardiomyopathy with anomalous mitral papillary muscles or chordae // J. thorac. cardiovasc. surg. - 2004. -№ 127. - Р. 481-489.
4. Michels M., Hoedemaekers Y. M., Kofflard M. J., et al. Familial screening and genetic counselling in hypertrophic cardiomyopathy: the Rotterdam experience // Neth. heart. j. -2007. - № 5. - Р. 184-190.
5. Morrow A. G., Koch J. P., Maron B. J., et al. // Left ventricular myotomy and myectomy in patients with obstructive hypertrophic cardiomyopathy and previous cardiac arrest // Am. j. of cardiology. - 1980. - № 46. - Р. 313-316.
6. Nugent A. W., Daubeney P. E., Chondros P., Carlin J. B., Colan S. D., Cheung M., Davis A. M., Chow C. W., Weintraub R. G. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study // Circulation. - 2005. - № 112. - Р. 1332-1338.
7. Schaff H. V, Dearani J. A., Ommen S. R., et al. Expanding the indications for septal myectomy in patients with hypertrophic cardiomyopathy: results of operation in patients with latent obstruction // J. thorac. cardiovasc. surg. - 2012. - Feb. № 143 (2). - Р. 303-309. doi: 10. 1016/j. jtcvs. 2011.10.059.
8. Taylor R. W., Giordano C., Davidson M. M. et al. A homoplasmic mitochondrial transfer ribonucleic acid mutation as a cause of maternally inherited hypertrophic cardiomyopathy // J. Amer. col. cardiology. - 2003. - Vol. 41. № 10. - P. 1786-1796.
9. Thomas Z. Armel, Leslie A. Leinwand. A mutation in the beta-myosin rod associated with hypertrophic cardiomyopathy has an unexpected molecular phenotype // Biochem. biophys. res. commun. - 2010. - Vol. 391. - P. 352-356.
10. Yu E. H., Omran A. S., Wigle E. D., Williams W. G., Siu S. C., Rakowski H. Mitral regurgitation in hypertrophic obstructive cardiomyopathy: relationship to obstruction and relief with myectomy // J. Am. col. cardiol. - 2000. - № 36. - Р. 2219-2225.
Review
For citations:
Shapieva A.N., Fedulova S.V., Cherepenina N.L., Klimenko V.S., Podoliak D.G. The modern approach to the treatment of diffuse - generalized forms of hypertrophic cardiomyopathy in the cardiac surgery. Kuban Scientific Medical Bulletin. 2016;(1):147-150. (In Russ.)
Views:
195
Email this article 